News
After months of puzzling the world over the true efficacy of the Sinovac product, applications to the World Health Organization (WHO) and the EMA will now bring clarity. The formal approval procedures are the acid test for the data on Sinovac's vaccine. It is not only the reputation of the Chinese pharmaceutical industry that is at stake. Non-approval would be a serious setback for the global supply of vaccines.
By Redaktion Table
India is currently suffering more than any other country from the COVID-19 pandemic. China is offering help in this humanitarian catastrophe and wants to position itself as an alternative to the US. However, a tasteless tweet shows the state of relations between the two arch-rivals – even during COVID-19.
By Michael Radunski
Chancellor Merkel and head of government Li now openly admit that harmony no longer prevails everywhere in the intergovernmental relationship. Some of the disagreements are on show, however – especially since Germany continues to stand firmly behind the CAI.
By
Due to the COVID-19 pandemic and its travel restrictions, international schools in China are experiencing a boom. Foreign schools are still seen as a stepping stone to later enroll in a prestigious Western university. In the long term, however, Beijing wants to make its education sector less dependent on foreign countries.
By Frank Sieren
The former army doctor Jiang Yanyong will soon be 90 years old. He has been living under house arrest in Beijing for two years. He courageously exposed the Sars epidemic in 2003. Now, when he called on the party leadership for the second time to confront the unresolved legacy of its June 4, 1989, military campaign, Beijing imposed its political lockdown on the unfaltering man.
By Table.Briefings
From Asia to Latin America to Europe, China's vaccine diplomacy is causing a stir worldwide. The People's Republic has now pledged half a billion vaccine doses to the countries of the world. But the help does not come for free. Sometimes it's about territorial claims, sometimes about 5G networks or the end of diplomatic ties. In Brazil, Beijing is pulling off a real masterstroke. That has repercussions for the entire continent.
By Michael Radunski
How reasonable are China's COVID-related entry restrictions? The industry association VDMA fears that the quarantine and the need for special permits will remain in place for a long time. The association suspects Beijing wants to give Chinese competitors an advantage. But there are initial indications that entry conditions will be eased. And it is usually possible to negotiate certain quarantine details in China even now.
By Redaktion Table
China is one of the largest markets for the global beverage industry. The sugary drinks of yesteryear have long since ceased to be box office hits. Western beverage manufacturers will have to adapt – and switch to healthier products. Genki Forest from Beijing shows how this can be done.
By Ning Wang
The healthcare system in China has the task of keeping the world's most populous country healthy. Since 2016, it has been undergoing modernization for this purpose. All the news on this topic is available from the Table.Media editorial team.
The healthcare system in China is based on clinics and hospitals. There are no medical practices or family doctors, which is why the Chinese go to the hospital for every little thing. In some cases, they only go to the hospital to get a prescription for medication. Those who live in the countryside and get sick go to smaller clinics. More serious cases are treated in community health centers. Both facilities have the problem of being poorly equipped and suffering from a shortage of money. Many Chinese therefore go directly to the hospitals in the big cities, where there is often a shortage of doctors. The extremely unequal distribution of resources between urban and rural areas is also considered one of the biggest challenges facing the healthcare system in China. University hospitals and military hospitals are among the flagship facilities.
Financing for the healthcare system in China comes from private, government and statutory sources. In 2016, spending amounted to about six percent of gross domestic product. That is, about half as much as in Europe (ten percent) and one-third of U.S. spending (17 percent). 40.2 percent of health spending in China came from private sources, as calculated by the World Bank. The remaining 59.8 percent came from health insurance companies and the public purse. In Germany, the ratio is 15 percent to 85 percent. Overall, per capita spending is $440.9 per year (2017). In Germany, it was already $5,600 in 2019. In the world's most populous country, there are a total of two doctors per 1,000 inhabitants. In Germany, for comparison, there are 4.5. For years, the Chinese Communist Party has therefore been trying to expand the healthcare system.
Almost all Chinese have access to health care in the People's Republic. As early as 2011, the coverage of China's health insurance system was 95 percent. To achieve this, the Communist Party has launched three insurance programs: UEBMI: For white-collar workers in urban areas. URBMI: For children, unemployed or disabled people in urban regions. NRCMS: For the rural population. However, some of the health insurance plans in China require the insured to pay a high co-payment. Only the UEBMI covers 68 percent of the costs of a hospital stay. In rural areas, the figure is only 44 percent. A major problem is the care of migrant workers. Most of them are insured through the NRCMS in their home towns and often cannot afford treatment in the city.
Traditional Chinese medicine (TCM) plays an important role in the healthcare system in China. Healing medicine in China accounts for between ten and twenty percent of Chinese healthcare. China's head of state Xi Jinping actively supports the healing arts, which is why the offerings are growing. From a scientific point of view, however, the central treatment methods of acupuncture, moxibustion, tuina anmo, shiatsu, qigong and taijiquan are controversial and considered pseudoscientific.
The diet of the Chinese is classically based on a lot of rice, grains and cooked vegetables. In addition, there is little fish and meat. Dairy products are hardly used in traditional cuisine. Nutrition is a pillar of treatment in Chinese medicine. It is based on the five elements, i.e. all five tastes - sweet, sour, salty, bitter and umami. Ideally, all five are represented in every meal to support all organs in their function.
The role of the pharmaceutical industry in healthcare in China depends heavily on the fact that pharma is a growth market in China. Accordingly, the importance of the pharmaceutical industry in the People's Republic will increase in the coming years. As part of the Healthy China 2030 plan, domestic research and production are to be strengthened. To this end, financial support programs are in place to make this sector more competitive internationally and to increase the number of patents. To this end, work is being done on innovation centers and pharmaceutical clusters. China has already achieved initial successes in the fight against the coronavirus. Sinopharm and Sinovac were able to deliver corona vaccines in record time. Both companies have developed a so-called dead vaccine. From Cansino Biologics came a vector vaccine.
Back in 2016, the Chinese Communist Party decided to reform China's healthcare system in a way. Under the title Healthy China 2030, policymakers unveiled an ambitious development plan to improve health in China. The goal is to increase life expectancy by three years to a total of 79 years by 2030 and to reduce the premature mortality rate from chronic diseases by thirty percent. To achieve this, healthcare spending is to be massively increased so that there are more doctors in China. Rural areas in particular are to receive better care. The Healthy China 2030 program also focuses on disease prevention and health promotion. For example, the number of people who regularly exercise is to increase from 360 million in the reference year 2014 to 530 million. The use of traditional Chinese medicine, i.e. medicine without drugs, is also to be supported. Healthy food and a balanced diet are also elementary.
Digitalization in particular is intended to improve the healthcare system in China. Accordingly, startups play a significant role in the field of e-health. Investments are high. Powerful companies are trying to capture the market early with start-ups. For example, Ping An, a major insurer, founded the portal Good Doctors. It offers online consultations, hospital referrals and appointments, health management and wellness interaction services. Alibaba also has its own health division, Alibaba Health. It focuses on online pharmaceutical retail, online consultations and drug prescription. Tencent has established WeDoctor Healthcare. It is divided into healthcare, cloud, insurance and pharmaceutical businesses. The Internet conglomerate also funds a variety of healthcare startups. In 2018 alone - the last full fiscal year before the Corona crisis - $42.8 billion in venture capital flowed, McKinsey calculated. About 1,000 health tech startups existed in China as of September 2019. The Corona crisis, in particular, has driven the digitization of healthcare in China. During the height of the pandemic, half of healthcare in the People's Republic could already be done online, the World Health Organization (WHO) estimates.
The modernization and expansion of the healthcare system in China is of central importance to the people of the People's Republic. Abroad, the large number of healthcare startups in particular is arousing interest, as they offer lucrative investment opportunities. Table.Media's editorial team has all the news on the topic.